Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Opioids Drug market report explains the definition, types, applications, major countries, and major players of the Opioids Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Depomed
Purdue
Yunnan Baiyao
Grunenthal
Teva
Sanofi
AstraZeneca
Pfizer
Endo
GSK
Bayer
Eli Lilly
Merck
J&J
Allergan
By Type:
Generic
Branded
By End-User:
Hospitals
Clinics
Drugstores
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Opioids Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Opioids Drug Outlook to 2028- Original Forecasts
-
2.2 Opioids Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Opioids Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Opioids Drug Market- Recent Developments
-
6.1 Opioids Drug Market News and Developments
-
6.2 Opioids Drug Market Deals Landscape
7 Opioids Drug Raw Materials and Cost Structure Analysis
-
7.1 Opioids Drug Key Raw Materials
-
7.2 Opioids Drug Price Trend of Key Raw Materials
-
7.3 Opioids Drug Key Suppliers of Raw Materials
-
7.4 Opioids Drug Market Concentration Rate of Raw Materials
-
7.5 Opioids Drug Cost Structure Analysis
-
7.5.1 Opioids Drug Raw Materials Analysis
-
7.5.2 Opioids Drug Labor Cost Analysis
-
7.5.3 Opioids Drug Manufacturing Expenses Analysis
8 Global Opioids Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Opioids Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Opioids Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Opioids Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Opioids Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Generic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Branded Consumption and Growth Rate (2017-2022)
-
9.2 Global $Opioids Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drugstores Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Opioids Drug Market Analysis and Outlook till 2022
-
10.1 Global Opioids Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Opioids Drug Consumption (2017-2022)
-
10.2.2 Canada Opioids Drug Consumption (2017-2022)
-
10.2.3 Mexico Opioids Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Opioids Drug Consumption (2017-2022)
-
10.3.2 UK Opioids Drug Consumption (2017-2022)
-
10.3.3 Spain Opioids Drug Consumption (2017-2022)
-
10.3.4 Belgium Opioids Drug Consumption (2017-2022)
-
10.3.5 France Opioids Drug Consumption (2017-2022)
-
10.3.6 Italy Opioids Drug Consumption (2017-2022)
-
10.3.7 Denmark Opioids Drug Consumption (2017-2022)
-
10.3.8 Finland Opioids Drug Consumption (2017-2022)
-
10.3.9 Norway Opioids Drug Consumption (2017-2022)
-
10.3.10 Sweden Opioids Drug Consumption (2017-2022)
-
10.3.11 Poland Opioids Drug Consumption (2017-2022)
-
10.3.12 Russia Opioids Drug Consumption (2017-2022)
-
10.3.13 Turkey Opioids Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Opioids Drug Consumption (2017-2022)
-
10.4.2 Japan Opioids Drug Consumption (2017-2022)
-
10.4.3 India Opioids Drug Consumption (2017-2022)
-
10.4.4 South Korea Opioids Drug Consumption (2017-2022)
-
10.4.5 Pakistan Opioids Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Opioids Drug Consumption (2017-2022)
-
10.4.7 Indonesia Opioids Drug Consumption (2017-2022)
-
10.4.8 Thailand Opioids Drug Consumption (2017-2022)
-
10.4.9 Singapore Opioids Drug Consumption (2017-2022)
-
10.4.10 Malaysia Opioids Drug Consumption (2017-2022)
-
10.4.11 Philippines Opioids Drug Consumption (2017-2022)
-
10.4.12 Vietnam Opioids Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Opioids Drug Consumption (2017-2022)
-
10.5.2 Colombia Opioids Drug Consumption (2017-2022)
-
10.5.3 Chile Opioids Drug Consumption (2017-2022)
-
10.5.4 Argentina Opioids Drug Consumption (2017-2022)
-
10.5.5 Venezuela Opioids Drug Consumption (2017-2022)
-
10.5.6 Peru Opioids Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Opioids Drug Consumption (2017-2022)
-
10.5.8 Ecuador Opioids Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Opioids Drug Consumption (2017-2022)
-
10.6.2 Kuwait Opioids Drug Consumption (2017-2022)
-
10.6.3 Oman Opioids Drug Consumption (2017-2022)
-
10.6.4 Qatar Opioids Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Opioids Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Opioids Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Opioids Drug Consumption (2017-2022)
-
10.7.2 South Africa Opioids Drug Consumption (2017-2022)
-
10.7.3 Egypt Opioids Drug Consumption (2017-2022)
-
10.7.4 Algeria Opioids Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Opioids Drug Consumption (2017-2022)
-
10.8.2 New Zealand Opioids Drug Consumption (2017-2022)
11 Global Opioids Drug Competitive Analysis
-
11.1 Depomed
-
11.1.1 Depomed Company Details
-
11.1.2 Depomed Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Depomed Opioids Drug Main Business and Markets Served
-
11.1.4 Depomed Opioids Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Purdue
-
11.2.1 Purdue Company Details
-
11.2.2 Purdue Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Purdue Opioids Drug Main Business and Markets Served
-
11.2.4 Purdue Opioids Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Yunnan Baiyao
-
11.3.1 Yunnan Baiyao Company Details
-
11.3.2 Yunnan Baiyao Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Yunnan Baiyao Opioids Drug Main Business and Markets Served
-
11.3.4 Yunnan Baiyao Opioids Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Grunenthal
-
11.4.1 Grunenthal Company Details
-
11.4.2 Grunenthal Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Grunenthal Opioids Drug Main Business and Markets Served
-
11.4.4 Grunenthal Opioids Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Teva
-
11.5.1 Teva Company Details
-
11.5.2 Teva Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Teva Opioids Drug Main Business and Markets Served
-
11.5.4 Teva Opioids Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Sanofi
-
11.6.1 Sanofi Company Details
-
11.6.2 Sanofi Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Sanofi Opioids Drug Main Business and Markets Served
-
11.6.4 Sanofi Opioids Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 AstraZeneca
-
11.7.1 AstraZeneca Company Details
-
11.7.2 AstraZeneca Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 AstraZeneca Opioids Drug Main Business and Markets Served
-
11.7.4 AstraZeneca Opioids Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pfizer
-
11.8.1 Pfizer Company Details
-
11.8.2 Pfizer Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pfizer Opioids Drug Main Business and Markets Served
-
11.8.4 Pfizer Opioids Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Endo
-
11.9.1 Endo Company Details
-
11.9.2 Endo Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Endo Opioids Drug Main Business and Markets Served
-
11.9.4 Endo Opioids Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 GSK
-
11.10.1 GSK Company Details
-
11.10.2 GSK Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 GSK Opioids Drug Main Business and Markets Served
-
11.10.4 GSK Opioids Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Bayer
-
11.11.1 Bayer Company Details
-
11.11.2 Bayer Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Bayer Opioids Drug Main Business and Markets Served
-
11.11.4 Bayer Opioids Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Eli Lilly
-
11.12.1 Eli Lilly Company Details
-
11.12.2 Eli Lilly Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Eli Lilly Opioids Drug Main Business and Markets Served
-
11.12.4 Eli Lilly Opioids Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Merck
-
11.13.1 Merck Company Details
-
11.13.2 Merck Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Merck Opioids Drug Main Business and Markets Served
-
11.13.4 Merck Opioids Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 J&J
-
11.14.1 J&J Company Details
-
11.14.2 J&J Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 J&J Opioids Drug Main Business and Markets Served
-
11.14.4 J&J Opioids Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Allergan
-
11.15.1 Allergan Company Details
-
11.15.2 Allergan Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Allergan Opioids Drug Main Business and Markets Served
-
11.15.4 Allergan Opioids Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global Opioids Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Opioids Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Generic Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Branded Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Opioids Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Drugstores Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Opioids Drug Market Analysis and Outlook to 2028
-
13.1 Global Opioids Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Opioids Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Opioids Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Opioids Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Opioids Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Opioids Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Opioids Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Opioids Drug Consumption Forecast (2022-2028)
-
13.3.5 France Opioids Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Opioids Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Opioids Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Opioids Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Opioids Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Opioids Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Opioids Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Opioids Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Opioids Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Opioids Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Opioids Drug Consumption Forecast (2022-2028)
-
13.4.3 India Opioids Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Opioids Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Opioids Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Opioids Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Opioids Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Opioids Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Opioids Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Opioids Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Opioids Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Opioids Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Opioids Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Opioids Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Opioids Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Opioids Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Opioids Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Opioids Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Opioids Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Opioids Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Opioids Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Opioids Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Opioids Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Opioids Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Opioids Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Opioids Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Opioids Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Opioids Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Opioids Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Opioids Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Opioids Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Opioids Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Opioids Drug
-
Figure of Opioids Drug Picture
-
Table Global Opioids Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Opioids Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Generic Consumption and Growth Rate (2017-2022)
-
Figure Global Branded Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstores Consumption and Growth Rate (2017-2022)
-
Figure Global Opioids Drug Consumption by Country (2017-2022)
-
Table North America Opioids Drug Consumption by Country (2017-2022)
-
Figure United States Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Opioids Drug Consumption by Country (2017-2022)
-
Figure Germany Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure France Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Opioids Drug Consumption by Country (2017-2022)
-
Figure China Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure India Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table South America Opioids Drug Consumption by Country (2017-2022)
-
Figure Brazil Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Opioids Drug Consumption by Country (2017-2022)
-
Figure Bahrain Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Opioids Drug Consumption by Country (2017-2022)
-
Figure Nigeria Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Opioids Drug Consumption by Country (2017-2022)
-
Figure Australia Opioids Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Opioids Drug Consumption and Growth Rate (2017-2022)
-
Table Depomed Company Details
-
Table Depomed Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed Opioids Drug Main Business and Markets Served
-
Table Depomed Opioids Drug Product Portfolio
-
Table Purdue Company Details
-
Table Purdue Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Opioids Drug Main Business and Markets Served
-
Table Purdue Opioids Drug Product Portfolio
-
Table Yunnan Baiyao Company Details
-
Table Yunnan Baiyao Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yunnan Baiyao Opioids Drug Main Business and Markets Served
-
Table Yunnan Baiyao Opioids Drug Product Portfolio
-
Table Grunenthal Company Details
-
Table Grunenthal Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grunenthal Opioids Drug Main Business and Markets Served
-
Table Grunenthal Opioids Drug Product Portfolio
-
Table Teva Company Details
-
Table Teva Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Opioids Drug Main Business and Markets Served
-
Table Teva Opioids Drug Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Opioids Drug Main Business and Markets Served
-
Table Sanofi Opioids Drug Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Opioids Drug Main Business and Markets Served
-
Table AstraZeneca Opioids Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Opioids Drug Main Business and Markets Served
-
Table Pfizer Opioids Drug Product Portfolio
-
Table Endo Company Details
-
Table Endo Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Endo Opioids Drug Main Business and Markets Served
-
Table Endo Opioids Drug Product Portfolio
-
Table GSK Company Details
-
Table GSK Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Opioids Drug Main Business and Markets Served
-
Table GSK Opioids Drug Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Opioids Drug Main Business and Markets Served
-
Table Bayer Opioids Drug Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Opioids Drug Main Business and Markets Served
-
Table Eli Lilly Opioids Drug Product Portfolio
-
Table Merck Company Details
-
Table Merck Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Opioids Drug Main Business and Markets Served
-
Table Merck Opioids Drug Product Portfolio
-
Table J&J Company Details
-
Table J&J Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table J&J Opioids Drug Main Business and Markets Served
-
Table J&J Opioids Drug Product Portfolio
-
Table Allergan Company Details
-
Table Allergan Opioids Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Opioids Drug Main Business and Markets Served
-
Table Allergan Opioids Drug Product Portfolio
-
Figure Global Generic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Branded Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opioids Drug Consumption Forecast by Country (2022-2028)
-
Table North America Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure China Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Opioids Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Opioids Drug Consumption Forecast and Growth Rate (2022-2028)
-
